Contrasting Ex Vivo Efficacies of “Reversed Chloroquine” Compounds in Chloroquine-Resistant Plasmodium falciparum and P. vivax Isolates

Chloroquine (CQ) has been the mainstay of malaria treatment for more than 60 years. However, the emergence and spread of CQ resistance now restrict its use to only a few areas where malaria is endemic. The aim of the present study was to investigate whether a novel combination of a CQ-like moiety an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Wirjanata, Grennady, Sebayang, Boni F., Chalfein, Ferryanto, Prayoga, Handayuni, Irene, Noviyanti, Rintis, Kenangalem, Enny, Poespoprodjo, Jeanne Rini, Burgess, Steven J., Peyton, David H., Price, Ric N., Marfurt, Jutta
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2015
Matèries:
Susceptibility
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4538531/
https://ncbi.nlm.nih.gov/pubmed/26149984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01048-15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars